[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
- PMID: 35918492
- DOI: 10.1007/s00259-022-05887-6
[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
Comment on
-
In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models.Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4073-4087. doi: 10.1007/s00259-022-05854-1. Epub 2022 Jun 10. Eur J Nucl Med Mol Imaging. 2022. PMID: 35680737
Similar articles
-
Development of an automated production process of [64 Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications.J Labelled Comp Radiopharm. 2022 Jun 15;65(7):191-202. doi: 10.1002/jlcr.3973. Epub 2022 Apr 29. J Labelled Comp Radiopharm. 2022. PMID: 35466453 Free PMC article.
-
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.Nucl Med Biol. 2008 Apr;35(3):273-9. doi: 10.1016/j.nucmedbio.2007.11.012. Nucl Med Biol. 2008. PMID: 18355682 Free PMC article.
-
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).J Nucl Med. 2006 Jun;47(6):989-98. J Nucl Med. 2006. PMID: 16741309
-
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.Q J Nucl Med Mol Imaging. 2020 Dec;64(4):371-381. doi: 10.23736/S1824-4785.20.03285-9. Epub 2020 Oct 7. Q J Nucl Med Mol Imaging. 2020. PMID: 33026209 Review.
-
Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.Chem Soc Rev. 2011 May;40(5):3005-18. doi: 10.1039/c0cs00215a. Epub 2011 Mar 15. Chem Soc Rev. 2011. PMID: 21409228 Review.
Cited by
-
In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3576-3588. doi: 10.1007/s00259-023-06310-4. Epub 2023 Jun 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37382663 Free PMC article.
-
Relationship between renal oxidative stress levels and disease severity in patients with chronic kidney disease assessed by [Cu-64]ATSM PET/MRI.Sci Rep. 2025 Feb 28;15(1):7227. doi: 10.1038/s41598-024-85027-2. Sci Rep. 2025. PMID: 40021767 Free PMC article.
-
CuATSM Enhances Wound Repair Without Scarring via Hippo/YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation.J Cell Mol Med. 2025 Jun;29(12):e70590. doi: 10.1111/jcmm.70590. J Cell Mol Med. 2025. PMID: 40525915 Free PMC article.
-
Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress.ACS Omega. 2024 Oct 17;9(43):43376-43384. doi: 10.1021/acsomega.4c03152. eCollection 2024 Oct 29. ACS Omega. 2024. PMID: 39493999 Free PMC article.
-
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives.Front Pharmacol. 2025 May 8;16:1559236. doi: 10.3389/fphar.2025.1559236. eCollection 2025. Front Pharmacol. 2025. PMID: 40406488 Free PMC article. Review.
References
-
- Nam B, Lee W, Sarkar S, Kim JH, Bhise A, Park H, et al. In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-05854-1 .
-
- Jain P, Chaney AM, Carlson ML, Jackson IM, Rao A, James ML. Neuroinflammation PET imaging: current opinion and future directions. J Nucl Med : Off Publ Soc Nucl Med. 2020;61:1107–12. https://doi.org/10.2967/jnumed.119.229443 . - DOI
-
- Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiat. 2020;7:1064–74. https://doi.org/10.1016/s2215-0366(20)30255-8 . - DOI
-
- Kreisl WC, Kim M-J, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020;19:940–50. https://doi.org/10.1016/s1474-4422(20)30346-x . - DOI - PubMed - PMC
-
- Wu C, Li F, Niu G, Chen X. PET imaging of inflammation biomarkers. Theranostics. 2013;3:448–66. https://doi.org/10.7150/thno.6592 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical